Covington Capital Management - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Covington Capital Management ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2022$6,000
-33.3%
1,0000.0%0.00%
Q2 2022$9,000
+12.5%
1,0000.0%0.00%
Q1 2022$8,000
-20.0%
1,0000.0%0.00%
Q4 2021$10,000
-47.4%
1,0000.0%0.00%
-100.0%
Q3 2021$19,000
+5.6%
1,0000.0%0.00%0.0%
Q2 2021$18,000
+50.0%
1,0000.0%0.00%0.0%
Q1 2021$12,000
-29.4%
1,0000.0%0.00%0.0%
Q4 2020$17,000
+70.0%
1,0000.0%0.00%
Q3 2020$10,000
+100.0%
1,0000.0%0.00%
Q2 2020$5,000
+66.7%
1,0000.0%0.00%
Q1 2020$3,000
-50.0%
1,0000.0%0.00%
Q4 2019$6,0000.0%1,0000.0%0.00%
Q3 2019$6,0001,0000.00%
Other shareholders
INMUNE BIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 275,000$5,341,0002.77%
Fermata Advisors, LLC 12,830$249,0000.11%
DG Capital Management, LLC 20,000$388,0000.08%
YorkBridge Wealth Partners, LLC 10,369$201,0000.05%
Ikarian Capital, LLC 26,632$517,0000.04%
Financial Advocates Investment Management 16,667$324,0000.02%
Janney Montgomery Scott LLC 99,323$1,929,0000.01%
Belvedere Trading LLC 16,177$302,0000.01%
FNY Investment Advisers, LLC 800$15,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 17,200$334,0000.01%
View complete list of INMUNE BIO INC shareholders